medigraphic.com
ISSN 0035-0052 (Impreso)

2007, Número 4

<< Anterior Siguiente >>

Rev Mex Pediatr 2007; 74 (4)


Epidemiología del virus de la hepatitis C en niños

Álvarez-Hernández G, Sotelo-Cruz N, Cano-Rangel MA

Idioma: Español
Referencias bibliográficas: 89
Paginas: 161-170
Archivo PDF: 147.49 Kb.


RESUMEN

La infección por el virus de la hepatitis C representa un problema de salud pública que afecta a todos los grupos poblacionales en el mundo, y los servicios de salud están ya enfrentando serios retos debidos a la carga epidemiológica y financiera condicionada por la prevalencia e incidencia del padecimiento. La hepatitis C crónica es una de las principales causas de enfermedad hepática crónica en los adultos. En los niños, la infección es menos frecuente y presenta diferencias en su modo de adquisición, características epidemiológicas, curso clínico, criterios diagnósticos y manejo terapéutico. El propósito de esta revisión es examinar los aspectos epidemiológicos de la infección por el VHC en población pediátrica, detallando la magnitud y factores de riesgo asociados, así como los retos de vigilancia epidemiológica del padecimiento, se pretende contribuir con ello a un mejor entendimiento del problema en México.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization. Hepatitis C. Fact Sheet 164. Geneve, Switzerland. 2000. Recurso disponible online en: http://www.who.int/mediacentre/factsheets/fs164/en

  2. Desenclos JC. The challenge of hepatitis C surveillance. Eurosurveillance 2003; 8(5): 99-100

  3. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997; 26: 521-26.

  4. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003; 36(1): 47-53.

  5. Davaalkham D, Ojima T, Nymadawa P et al. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 2006; 78: 466-72.

  6. Zhang M, Sun XD, Mark SD, Chen W, Wong L et al. Hepatitis C virus infection, Linxian, China. Emerg Inf Dis 2005; 11(1): 17-21.

  7. Lin DB, Tsai TP, Chen WK. Seroprevalence of hepatitis C virus infection and its association with natural infection of hepatitis B virus among preschool children in Taiwan. Eur J Epidemiol 2003; 18: 245-49.

  8. Jain A, Rana SS, Chakravarty P, Gupta NS et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol 2003; 18: 695-97.

  9. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New Engl J Med 1999; 341: 556-62.

  10. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36: S30-S34.

  11. Strader DB, Wright T, Thomas DL, Seef LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39(4): 1147-71.

  12. Méndez-Sánchez N, Baptista-González H, Sánchez-Gómez RH et al. Prevalencia de hepatitis B y C en donadores de sangre de un hospital de tercer nivel de la ciudad de México. Salud Pública Mex 1999; 41: 475-78.

  13. Vivas-Arceo C, Aguilar-Benavides S, Trujillo JJ et al. Hepatitis C virus: prevalence and routes of infection among blood donors in West Mexico. Hepatol Res 2003; 25: 115-23.

  14. Rivera-López MR, Zavala-Méndez C, Arenas-Esqueda A. Prevalencia de seropositividad para VIH, hepatitis B y C en donadores de sangre. Gac Med Mex 2004; 140 (6): 657-660.

  15. Méndez-Sánchez N, Ponciano-Rodríguez G, Chávez-Tapia NC et al. Prevalence of hepatitis C infection in a population of asymptomatic people in a check-up unit in Mexico City. Digest Dis Sci 2005; 50(4): 733-37.

  16. Méndez-Sánchez N, Motola-Kuba D, Chávez-Tapia NC et al. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol 2004; 42(9): 4321-22.

  17. Secretaría de Salud. Boletín Epidemiológico de la Dirección General de Epidemiología 2001-2005. México. Recurso online disponible en http://www.dgepi.salud.gob.mx/boletin/boletin.htm

  18. Jonas MM. Children with hepatitis C. Hepatology 2002; 36: S173-S178.

  19. El-Kamary SS, Serwint JR, Joffe A et al. Prevalence of hepatitis C virus infection in urban children. J Pediatr 2003; 143: 54-9.

  20. England K, Pembrey L, Tovo PA, Newell ML. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV infected mothers. Act Paediat 2005: 444-50.

  21. Jara P, Resti M, Hierro L, Giacchino R et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003; 36: 275-80.

  22. Jye-Bin L, Ding-Bang L, Shiuan-Chih C et al. Seroepidemiology of hepatitis A, B, C and E viruses infection among preschool children in Taiwan. J Med Virol 2006; 78: 18-23.

  23. Goldberg D, McIntyre PG, Smith R et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinkedanonymous testing. Br J Obstet Gynaecol 2001; 108: 365-70.

  24. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002; 36: S106-S113.

  25. Silverman NS, Jenkin BK, Wu C et al. Hepatitis C virus in pregnancy: seroprevalence and risk factors for infection. Am J Obstet Gynecol 1993; 169: 583-87.

  26. Karim B, Alex G, Smith AL, Hardikar W. Hepatitis C infection in children: a Melbourne perspective. J Paediatr Child Health 2000; 36: 385-88.

  27. Laurent C, Henzel D, Mulanga-Kabeya C et al. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 2001; 30: 872-77.

  28. Plunkett BA, Grobman WA. Routine hepatitis C virus screening in pregnancy: a cost-effective analysis. Am J Obstet Gynecol 2005; 192: 1153-61.

  29. Njouom R, Pasquier C, Ayouba A et al. Hepatitis C virus infection among pregnant women in Yaounde: prevalence, viremia, and genotypes. J Med Virol 2003; 69: 384-390.

  30. Gibb DM, Goodall RL, Dunn DT et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000; 356: 904-7.

  31. Pembrey L, Tovo PA, Newell ML. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. Br J Obstet Gynaecol 2001; 108: 31-77.

  32. Santiago-Muñoz P, Roberts S, Sheffield J et al. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. Am J Obstet Gynecol 2005; 193: 1270-73.

  33. Flamm SL. Chronic hepatitis C virus infection. JAMA 2003; 289(18): 2413-17.

  34. Tahan V, Karaca C, Yildirim B et al. Sexual transmission of HCV between spouses. Am J Gastroenterol 2005; 100: 821-24.

  35. Centers for Disease Prevention and Control. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47: 1-33.

  36. Choy Y, Gittens-Williams L, Apuzzio J et al. Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients. Infect Dis Obstet Gynecol 2003; 11: 191-98.

  37. Mesquita PE, Hernández-Granato CF, Castelo A. Risk factors associated with hepatitis C virus (HCV) infection among prostitutes and their clients in the city of Santos, Sao Paulo State, Brazil. J Med Virol 1997; 51: 338-43.

  38. Thomas DL, Zenilman JM, Alter HJ et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 partnerships. J Infect Dis 1995; 171: 768-75.

  39. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Sem Liver Dis 2000; 20(1): 1-16.

  40. Steininger C, Kundi M, Jatzko G et al. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 2003; 187: 345-51.

  41. Schackman BR, Oneda K, Goldie SJ. The cost-effectiveness of elective cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS 2004; 18: 1827-34.

  42. Arroyo-Carrera I, Martínez-Sapiña A, García-García J et al. Transmisión vertical del virus de la hepatitis C. Vox Paediatr 2003; 11(1): 7-11.

  43. Okamoto M, Nagata I, Murakami J et al. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000; 182: 1511-14.

  44. Mast EE, Hwang LY, Seto DSY et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192: 1880-9.

  45. Zuccotti GV, Ribero ML, Giovannini L et al. Effect of hepatitis C genotype on mother-to-infant transmission of virus. J Pediatr 1995; 127: 278-80.

  46. Zein NN. Vertical transmission of hepatitis C: to screen or not to screen? J Pediatr 1997; 130: 859-861 (Editorial).

  47. Lin HH, Kao JH, Hsu HY et al. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87: 244-8.

  48. Rumbo C. Hepatitis C: current approaches in pediatrics. Pediatr Transplantation 2005; 9: 662-65.

  49. Spencer JD, Latt N, Beeby PJ et al. Transmission of hepatitis C virus of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 1997; 4: 395-409.

  50. Healy CM, Cafferkey MT, Conroy A et al. Outcome of infants born to hepatitis C infected women. Ir J Med Sci 2001; 170: 103-176.

  51. Méndez-Sánchez N, Uribe M. Consenso Nacional sobre Hepatitis C. Conclusiones. Rev Invest Clin 2002; 54(6):559-568.

  52. Minola E, Maccabruni A, Pacati I, Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 33(5): 1341-42.

  53. Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus: a meta-analysis. Int J Epidemiol 2003; 32: 727-734.

  54. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol 2006; 44: S28-S34.

  55. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138: 197-207.

  56. Delahooke TES. What is the nature of the problem? J Viral Hepat 2004; 11(S1): 5-11.

  57. Mazza C, Ravaggi A, Rodella A. Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. J Med Virol 1998; 54: 12-19.

  58. Ruiz-Extremera A, Salmerón J, Torres C et al. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breastfeeding in transmission. Pediatr Infect Dis 2000; 19: 511-16.

  59. Ahktar S, Moatter T. Intra-household clustering of hepatitis C virus infection in Karachi, Pakistan. Trans R Soc Trop Med Hyg 2004; 98: 535-39.

  60. Mastromatteo AM, Rapaccini GL, Pompili M et al. Hepatitis C virus infection: other biological fluids than blood may be responsible for intrafamilial spread. Hepatogastroenterology 2001; 48: 193-96.

  61. Ahktar S, Moatter T, Azam SI et al. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. J Viral Hepat 2002; 9: 309-14.

  62. Lins L, Almeida H, Vitvisk L et al. Detection of hepatitis C virus RNA in saliva is not related to oral health status or viral load. J Med Virol 2005; 77:216-20.

  63. Goncalves PL, Cunha CB, Busek SCU et al. Detection of hepatitis C virus RNA in saliva samples from patients with seric anti-HCV antibodies. Braz J Infect Dis 2005; 9(1): 28-34.

  64. García CD. Tratamiento de la hepatitis aguda por virus C. Rev Gastroenterol Mex 2002; 67: 61-66.

  65. Mondragón ZF, Cervantes BR. Hepatitis por virus C. Rev Enfer Infec Pediatr 2006; 75: 69-70.

  66. Hierro LL. Hepatitis C. El virus, métodos de diagnóstico, epidemiología, enfermedad autolimitada y crónica. An Pediatr 2003; 58: 489-91.

  67. National Institutes of Health (NIH). National Institutes of Health Consensus Development Conference Statement: management of hepatitis C, 2002. Hepatology 2002; 36: S3-S21.

  68. American Academy of Pediatrics. Committee on Infectious Diseases. Hepatitis C virus infection. Pediatr 1998; 101 (3): 481-85.

  69. Hierro-Lanillo I. Hepatitis C. Hepatitis crónica. Evolución y tratamiento. An Pediatr 2003; 58(5): 486-88.

  70. Vences-Aviles MA, González-Bravo F. Diagnóstico de la infección por el virus de la hepatitis C en donadores de sangre. Rev Mex Patol Clin 2005; 52: 6-12.

  71. Calzado AM, Gómez RM, Cordova C, Asensi BF. Hepatitis C en la infancia, revisión de 41 casos en el Hospital Infantil La Fé (Valencia España) atendidos en los últimos 15 años. Rev Enfer Infec Pediatr 2006; 76; 107-111.

  72. Marmesa A, Ozkan T, Ozeke T. The efficacy of antiviral therapy in children with chronic hepatitis C compared to its natural course. J Pediatr Gastroenterology Nutr 2004; 39: 170.

  73. Schwimmer JB, Balistreri W. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Sem Liver Dis 2000; 20(1): 37-46.

  74. Jhaveri R, Grant W, Kauf TL et al. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 2006; 148: 353-8.

  75. Wong JB, McQuillan GM, McHutchinson JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-69.

  76. Howie H, Hutchinson SJ. What lies ahead and can we afford it? J Viral Hepat 2004; 11 (S1): 28-33.

  77. Latt NC, Spencer JD, Beeby PJ et al. Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol 2000; 15: 175-8.

  78. Houghton M. The hepatitis C virus: a new paradigm for the identification and control of infectious disease. Nature Med 2000; 6(10): 1084-6.

  79. Mathei C, Shkedy Z, Denis B et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. J Viral Hepat 2006; 13: 560-70.

  80. Haley RW, Fisher RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 662 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 2001; 80(2): 134-51.

  81. Haley RW, Fisher RP. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection. Arch Intern Med 2003; 163(9): 1095-8.

  82. Lee HW, Vasquez Y. Risk factors for hepatitis C on the Texas-Mexico Border. Am J Gastroenterol 2005; 100: 2180-5.

  83. Carithers RL, Marquardt A, Gretch DR. Diagnostic testing for hepatitis C. Sem Liver Dis 2000; 20(2): 159-71.

  84. Alter MJ, Seeff LB, Bacon BR et al. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004; 141: 715-7.

  85. Forns X, Costa J. HCV virological assessment. J Hepatol 2006; 44: S35-S39.

  86. Centers for Disease Prevention and Control. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Morb Mortal Wkly Rep 2001; 50(RR13): 1-35.

  87. Strauss B, Bigham M. Hepatitis C surveillance - are we doing enough? British Columbia, 2001. Can Commun Dis Report 2001; 28(18): 149-56.

  88. Academia Mexicana de Pediatría. Hepatitis virales crónicas en niños y adolescentes. Bol Med Hosp Infant Mex 2001; 58(3): 198-204.

  89. Goldberg D, Anderson E. Who is at risk and how do we identify them? J Viral Hepat 2004; 11(S1): 12-18.




2020     |     www.medigraphic.com